Neurophysiological characterization of high-dose magnetic seizure therapy: Comparisons with electroconvulsive shock and cognitive outcomes

Journal of ECT

Volumn 25, Issue 3, 2009, Pages 157-164

  Cycowicz, Yael M ^a   Luber, Bruce ^a   Spellman, Timothy ^a   Lisanby, Sarah H ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

EEG; Electroconvulsive therapy; Magnetic seizure therapy (MST); Primate

Indexed keywords

ALLOPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; CONVALESCENCE; ELECTRIC SHOCK; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; FREQUENCY MODULATION; MAGNETIC SEIZURE THERAPY; MAGNETOTHERAPY; MALE; NEUROPHYSIOLOGY; NONHUMAN; ORIENTATION; RHESUS MONKEY; SEIZURE THRESHOLD; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANESTHESIA; ANIMALS; COGNITION; DELTA RHYTHM; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; ELECTROMAGNETIC FIELDS; HUMANS; MACACA MULATTA; MALE; PSYCHOMOTOR PERFORMANCE; SEIZURES; TREATMENT OUTCOME;

EID: 70349135914     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e31818dd40a     Document Type: Article

References (27)

1. Luber B, Nobler MS, Moeller JR, et al. Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. II. Topographic analyses. J ECT. 2000;16(3):229-243.
2. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind compison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. ch Gen Psychiatry. 2000;57(5):425-434.
3. Lisanby SH. Update on magnetic seizure therapy: a novel form of convulsive therapy. J ECT. 2002;18(4):182-188.
4. Lisanby SH, Luber B, Finck AD, et al. Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. ch Gen Psychiatry. 2001;58(2):199-200.
5. Lisanby SH, Schlaepfer TE, Fisch HU, et al. Magnetic seizure therapy of major depression. ch Gen Psychiatry. 2001;58(3):303-305.
6. Lisanby SH, Moscrip T, Morales O, et al. Neurophysiological chacterization of magnetic seizure therapy (MST) in non-human primates. Suppl Clin Neurophysiol. 2003;56:81-99.
7. Scalia J, Lisanby SH, Underwood M, et al. The spatial distribution of mossy fiber sprouting in a non-human primate model for electroconvulsive therapy and magnetic seizure therapy. Biol Psychiatry. 2004;55:207S.
8. Cycowicz M, Luber B, Spellman T, et al. Differential neurophysiological effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS) in non-human primates. Clin EEG Neurosci. 2008;39(3):144-149.
9. Moscrip TD, Terrace HS, Sackeim HA, et al. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychophmacol. 2006; 9(1):1-11.
10. Lisanby SH, Luber B, Schlaepfer TE, et al. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject compison with electroconvulsive therapy. Neuropsychophmacology. 2003;28(10):1852-1865.
11. Sackeim HA, Decina P, Kanzler M, et al. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry. 1987; 144(11):1449-1455.
12. Sackeim HA, Decina P, Portnoy S, et al. Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry. 1987;22(3): 249-268.
13. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328(12):839-846.
14. Peterchev A, Kirov G, Ebmeier K, et al. Frontiers in TMS technology development: controllable pulse shape TMS (cTMS) and magnetic seizure therapy (MST) at 100 Hz. Biol Psychiatry. 2007;61:S107.
15. Kirov G, Ebmeier KP, Scott AI, et al. Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry. 2008;193(2):152-155.
16. Spellman T, McClintock SM, Terrace H, et al. Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biol Psychiatry. 2008;63(12):1163-1170.
17. Fink M, Kahn R. Relation of electroencephalographic delta activity to behavioral response in electroshock: quantitative serial studies. AMA ch Neurol Psychiatry. 1957;78(5):516-525.
18. Sackeim HA, Luber B, Katzman GP, et al. The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. ch Gen Psychiatry. 1996;53(9): 814-824.
19. Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT. 1999;15(1):5-26.
20. Moscrip TD, Terrace HS, Sackeim HA, et al. A primate model of anterograde and retrograde amnesia produced by convulsive treatment. J ECT. 2004;20(1):26-36.
21. American Psychiatric Association. The Practice of ECT: Recommendations for Treatment, Training and Privileging. 2nd ed. Washington, DC: American Psychiatric Press; 2001.
22. Steriade M, Gloor P, Llinas RR, et al. Report of IFCN Committee on Basic Mechanisms. Basic mechanisms of cerebral rhythmic activities. Electroencephalogr Clin Neurophysiol. 1990;76(6):481-508.
23. Huber R, Esser SK, Ferrelli F, et al. TMS-induced cortical potentiation during wakefulness locally increases slow wave activity during sleep. PLoS ONE. 2007;2(3):e276.
24. Soltesz I, Deschenes M. Low-and high-frequency membrane potential oscillations during theta activity in CA1 and CA3 pyramidal neurons of the rat hippocampus under ketamine-xylazine anesthesia. J Neurophysiol. 1993;70(1):97-116.
25. Nobler MS, Sackeim HA, Solomou M, et al. EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry. 1993;34(5):321-330.
26. Azuma H, Fujita A, Sato K, et al. Postictal suppression correlates with therapeutic efficacy for depression in bilateral sine and pulse wave electroconvulsive therapy. Psychiatry Clin Neurosci. 2007;61(2): 168-173.
27. Perera TD, Luber B, Nobler MS, et al. Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects. Neuropsychophmacology. 2004;29(4):813-825.